Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.

Hereditary breast cancer accounts for 5-10% of all breast cancer cases. So far, known genetic risk factors account for only 50% of the breast cancer genetic component and almost a quarter of hereditary cases are carriers of pathogenic mutations in BRCA1/2 genes. Hence, the genetic basis for a signif...

Full description

Saved in:
Bibliographic Details
Main Authors: Maroua Boujemaa, Yosr Hamdi, Nesrine Mejri, Lilia Romdhane, Kais Ghedira, Hanen Bouaziz, Houda El Benna, Soumaya Labidi, Hamza Dallali, Olfa Jaidane, Sonia Ben Nasr, Abderrazek Haddaoui, Khaled Rahal, Sonia Abdelhak, Hamouda Boussen, Mohamed Samir Boubaker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245362&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850241490088886272
author Maroua Boujemaa
Yosr Hamdi
Nesrine Mejri
Lilia Romdhane
Kais Ghedira
Hanen Bouaziz
Houda El Benna
Soumaya Labidi
Hamza Dallali
Olfa Jaidane
Sonia Ben Nasr
Abderrazek Haddaoui
Khaled Rahal
Sonia Abdelhak
Hamouda Boussen
Mohamed Samir Boubaker
author_facet Maroua Boujemaa
Yosr Hamdi
Nesrine Mejri
Lilia Romdhane
Kais Ghedira
Hanen Bouaziz
Houda El Benna
Soumaya Labidi
Hamza Dallali
Olfa Jaidane
Sonia Ben Nasr
Abderrazek Haddaoui
Khaled Rahal
Sonia Abdelhak
Hamouda Boussen
Mohamed Samir Boubaker
author_sort Maroua Boujemaa
collection DOAJ
description Hereditary breast cancer accounts for 5-10% of all breast cancer cases. So far, known genetic risk factors account for only 50% of the breast cancer genetic component and almost a quarter of hereditary cases are carriers of pathogenic mutations in BRCA1/2 genes. Hence, the genetic basis for a significant fraction of familial cases remains unsolved. This missing heritability may be explained in part by Copy Number Variations (CNVs). We herein aimed to evaluate the contribution of CNVs to hereditary breast cancer in Tunisia. Whole exome sequencing was performed for 9 BRCA negative cases with a strong family history of breast cancer and 10 matched controls. CNVs were called using the ExomeDepth R-package and investigated by pathway analysis and web-based bioinformatic tools. Overall, 483 CNVs have been identified in breast cancer patients. Rare CNVs affecting cancer genes were detected, of special interest were those disrupting APC2, POU5F1, DOCK8, KANSL1, TMTC3 and the mismatch repair gene PMS2. In addition, common CNVs known to be associated with breast cancer risk have also been identified including CNVs on APOBECA/B, UGT2B17 and GSTT1 genes. Whereas those disrupting SULT1A1 and UGT2B15 seem to correlate with good clinical response to tamoxifen. Our study revealed new insights regarding CNVs and breast cancer risk in the Tunisian population. These findings suggest that rare and common CNVs may contribute to disease susceptibility. Those affecting mismatch repair genes are of interest and require additional attention since it may help to select candidates for immunotherapy leading to better outcomes.
format Article
id doaj-art-def6bd33a2214e8aa81a2ffd6005199f
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-def6bd33a2214e8aa81a2ffd6005199f2025-08-20T02:00:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024536210.1371/journal.pone.0245362Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.Maroua BoujemaaYosr HamdiNesrine MejriLilia RomdhaneKais GhediraHanen BouazizHouda El BennaSoumaya LabidiHamza DallaliOlfa JaidaneSonia Ben NasrAbderrazek HaddaouiKhaled RahalSonia AbdelhakHamouda BoussenMohamed Samir BoubakerHereditary breast cancer accounts for 5-10% of all breast cancer cases. So far, known genetic risk factors account for only 50% of the breast cancer genetic component and almost a quarter of hereditary cases are carriers of pathogenic mutations in BRCA1/2 genes. Hence, the genetic basis for a significant fraction of familial cases remains unsolved. This missing heritability may be explained in part by Copy Number Variations (CNVs). We herein aimed to evaluate the contribution of CNVs to hereditary breast cancer in Tunisia. Whole exome sequencing was performed for 9 BRCA negative cases with a strong family history of breast cancer and 10 matched controls. CNVs were called using the ExomeDepth R-package and investigated by pathway analysis and web-based bioinformatic tools. Overall, 483 CNVs have been identified in breast cancer patients. Rare CNVs affecting cancer genes were detected, of special interest were those disrupting APC2, POU5F1, DOCK8, KANSL1, TMTC3 and the mismatch repair gene PMS2. In addition, common CNVs known to be associated with breast cancer risk have also been identified including CNVs on APOBECA/B, UGT2B17 and GSTT1 genes. Whereas those disrupting SULT1A1 and UGT2B15 seem to correlate with good clinical response to tamoxifen. Our study revealed new insights regarding CNVs and breast cancer risk in the Tunisian population. These findings suggest that rare and common CNVs may contribute to disease susceptibility. Those affecting mismatch repair genes are of interest and require additional attention since it may help to select candidates for immunotherapy leading to better outcomes.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245362&type=printable
spellingShingle Maroua Boujemaa
Yosr Hamdi
Nesrine Mejri
Lilia Romdhane
Kais Ghedira
Hanen Bouaziz
Houda El Benna
Soumaya Labidi
Hamza Dallali
Olfa Jaidane
Sonia Ben Nasr
Abderrazek Haddaoui
Khaled Rahal
Sonia Abdelhak
Hamouda Boussen
Mohamed Samir Boubaker
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
PLoS ONE
title Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
title_full Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
title_fullStr Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
title_full_unstemmed Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
title_short Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
title_sort germline copy number variations in brca1 2 negative families role in the molecular etiology of hereditary breast cancer in tunisia
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245362&type=printable
work_keys_str_mv AT marouaboujemaa germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT yosrhamdi germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT nesrinemejri germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT liliaromdhane germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT kaisghedira germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT hanenbouaziz germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT houdaelbenna germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT soumayalabidi germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT hamzadallali germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT olfajaidane germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT soniabennasr germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT abderrazekhaddaoui germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT khaledrahal germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT soniaabdelhak germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT hamoudaboussen germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia
AT mohamedsamirboubaker germlinecopynumbervariationsinbrca12negativefamiliesroleinthemolecularetiologyofhereditarybreastcancerintunisia